French Euroapi slumps on yearly guidance cut

Euroapi SA

17/12/2025 09:01

** Shares in France-based Euroapi fall roughly 12% to their lowest since early August, after the pharmaceuticals company cut its annual net sales outlook

** The firm said on Tuesday it expected that full-year net sales would decrease by mid-single digits versus previously guided decline of low-single digits

** "We expect the shares to underperform today given the 18% implied cuts to 2025 consensus Core EBITDA", J.P. Morgan analysts say in a note

** They add that the guidance cut additionally implies the full year sales will stand at around 866.3 million euros ($1.02 billion)

** Analysts at BNP Paribas Portzamparc also cut Euroapi's rating to "hold" from "accumulate" following the guidance change

** Out of five analysts that cover the French firm, ​one rates the stock at "buy", ​​two rate it at "hold" and two​ at "strong sell" or "sell", according to LSEG data

($1 = 0.8533 euros)

 (Reporting by Mateusz Rabiega)

 ((Mateusz.rabiega@thomsonreuters.com))